➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Baxter
Colorcon
Johnson and Johnson
McKinsey

Last Updated: October 23, 2020

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of patent protection?

Triamcinolone acetonide is the generic ingredient in twenty-six branded drugs marketed by Abbvie, Sanofi Aventis Us, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin Atlantis, Macleods Pharms Ltd, MLV, Morton Grove, Mylan, Perrigo New York, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Teligent Pharma Inc, Topiderm, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Amneal, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Quagen, Saptalis Pharms, Wockhardt Bio Ag, Encube, Glenmark Pharms, Novel Labs Inc, Cmp Pharma Inc, Lyne, Perrigo Israel, Sun Pharm Inds Inc, Perrigo Uk Finco, and Rising, and is included in one hundred and twenty-nine NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has seventy-three patent family members in twenty-five countries.

There are fifty-one drug master file entries for triamcinolone acetonide. Seventy suppliers are listed for this compound.

Drug Prices for triamcinolone acetonide

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of South FloridaPhase 3
ghada fouadPhase 2/Phase 3
Memorial Sloan Kettering Cancer CenterPhase 2

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 011602-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Taro TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 086277-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 087922-001 Aug 10, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Cosette TRIAMCINOLONE ACETONIDE triamcinolone acetonide LOTION;TOPICAL 089129-001 Aug 14, 1986 AT RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa TRIAMCINOLONE ACETONIDE triamcinolone acetonide INJECTABLE;INJECTION 209852-001 Oct 5, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Astellas ARISTOCORT A triamcinolone acetonide CREAM;TOPICAL 083016-005 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982   Start Trial   Start Trial
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013   Start Trial   Start Trial
Novartis TRIESENCE triamcinolone acetonide INJECTABLE;INTRAVITREAL 022048-001 Nov 29, 2007   Start Trial   Start Trial
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013   Start Trial   Start Trial
Sanofi Aventis Us NASACORT triamcinolone acetonide AEROSOL, METERED;NASAL 019798-001 Jul 11, 1991   Start Trial   Start Trial
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Dow
Moodys
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.